Premium
Treating head and neck tumors during the SARS‐CoV ‐2 epidemic, 2019 to 2020: Sichuan Cancer Hospital
Author(s) -
Cai YongCong,
Wang Wei,
Li Chao,
Zeng Dinfen,
Zhou YuQiu,
Sun RongHao,
Jiang Hua,
Guo Hui,
Wang ShaoXin,
Jiang Jian
Publication year - 2020
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.26161
Subject(s) - china , medicine , head and neck , covid-19 , public health , head and neck cancer , pandemic , pneumonia , disease control , general surgery , cancer , family medicine , medical emergency , disease , environmental health , infectious disease (medical specialty) , surgery , geography , pathology , archaeology
Since December 2019, a number of patients with novel coronavirus pneumonia (NCP) have been identified in Wuhan, Hubei Province, China. NCP has rapidly spread to other provinces and cities in China and other countries in the world. Due to the rapid increase in reported cases in China and around the world, on January 30, 2020, the World Health Organization (WHO) Emergency Committee announced that NCP is a Public Health Emergency of International Concern (PHEIC). However, there are relatively few suggestions and measures for tumor patients, especially patients with head and neck tumors. This article summarizes the prevention and control of disease in our medical institution to provide a reference for front‐line head and neck surgeons.